Ataxia / инсульт

Immortalized human microglia cell line

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

RESEARCH SUPPORT The research for the present invention was supported in part by grants from the Multiple Sclerosis Society of Canada and the Canadian Myelin Research Initiative. FIELD OF THE INVENTION The present invention is concerned generally with glial cell components of the central nervous

Movement disorder therapy system, devices and methods, and intelligent methods of tuning

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

BACKGROUND OF THE INVENTION (1) Field of the Invention The present invention relates to therapeutic medical apparatus systems, delivery systems, devices and/or methods, and to apparatus and methods for using neural stimulation to alleviate the symptoms of movement disorders, such as those associated

Movement disorder therapy system, devices and methods, and intelligent methods of tuning

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

BACKGROUND OF THE INVENTION (1) Field of the Invention The present invention relates to therapeutic medical apparatus systems, delivery systems, devices and/or methods, and to apparatus and methods for using neural stimulation to alleviate the symptoms of movement disorders, such as those associated

Movement disorder therapy system, devices and methods, and intelligent methods of tuning

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

BACKGROUND OF THE INVENTION (1) Field of the Invention The present invention relates to therapeutic medical apparatus systems, delivery systems, devices and/or methods, and to apparatus and methods for using neural stimulation to alleviate the symptoms of movement disorders, such as those associated

Human I.kappa.B-.beta.

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

FIELD OF INVENTION This invention relates to newly identified polynucleotides, polypeptides encoded by them and to the use of such polynucleotides and polypeptides, and to their production. More particularly, the polynucleotides and polypeptides of the present invention relate to the I.kappa.B

Intranasal compositions

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

CROSS-REFERENCE TO RELATED APPLICATIONS This application is a Section 371 of International Application No. PCT/GB2004/005446, filed Dec. 23, 2004, which was published in the English language on Jul. 7, 2005, under International Publication No. WO 2005/060945 A2 and the disclosure of which is

Inhibitors of transcription factor-NF-.kappa.B

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

FIELD OF THE INVENTION This invention relates in general to salicylanilide inhibitors of transcription factor NF-.kappa.B. Such compounds are particularly useful for treating diseases in which activation of NF-.kappa.B is implicated. More specifically, these compounds inhibit I.kappa.B

Movement disorder therapy system and methods of tuning remotely, intelligently and/or automatically

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

BACKGROUND OF THE INVENTION (1) Field of the Invention The present invention relates to therapeutic medical apparatus systems, delivery systems, devices and/or methods, and to apparatus and methods for using neural stimulation to alleviate the symptoms of movement disorders, such as those associated

Movement disorder therapy system and methods of tuning remotely, intelligently and/or automatically

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

BACKGROUND OF THE INVENTION (1) Field of the Invention The present invention relates to therapeutic medical apparatus systems, delivery systems, devices and/or methods, and to apparatus and methods for using neural stimulation to alleviate the symptoms of movement disorders, such as those associated

Movement disorder therapy system, devices and methods, and methods of remotely tuning

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

BACKGROUND OF THE INVENTION (1) Field of the Invention The present invention relates to therapeutic medical apparatus systems, delivery systems, devices and/or methods, and to apparatus and methods for using neural stimulation to alleviate the symptoms of movement disorders, such as those associated

Movement disorder therapy system and methods of tuning remotely, intelligently and/or automatically

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

BACKGROUND OF THE INVENTION (1) Field of the Invention The present invention relates to therapeutic medical apparatus systems, delivery systems, devices and/or methods, and to apparatus and methods for using neural stimulation to alleviate the symptoms of movement disorders, such as those associated

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of Neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

BACKGROUND OF THE INVENTION Brain-derived neurotrophic factor (BDNF) is one of several endogenous proteins that play key roles in neuronal development. BDNF influences nerve growth as a neurotrophin and/or as a myokine. Therefore there is a need for improved methods for inducing expression of BDNF.

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

BACKGROUND OF THE INVENTION Brain-derived neurotrophic factor (BDNF) is one of several endogenous proteins that play key roles in neuronal development. BDNF influences nerve growth as a neurotrophin and/or as a myokine. Therefore there is a need for improved methods for inducing expression of BDNF.

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

BACKGROUND OF THE INVENTION Brain-derived neurotrophic factor (BDNF) is one of several endogenous proteins that play key roles in neuronal development. BDNF influences nerve growth as a neurotrophin and/or as a myokine. Therefore there is a need for improved methods for inducing expression of BDNF.

Activators of class I histone deacetlyases (HDACs) and uses thereof

Только зарегистрированные пользователи могут переводить статьи

Войти Зарегистрироваться

FIELD OF THE INVENTION The field of the invention pertains to activators of class I histone deacetylases and their uses in the treatment of neurological disorders. BACKGROUND OF THE INVENTION In a variety of neurodegenerative disorders such as ischemia and Alzheimer's disease (Hayashi et al.,

ataxia/инсульт

Immortalized human microglia cell line

Movement disorder therapy system, devices and methods, and intelligent methods of tuning

Movement disorder therapy system, devices and methods, and intelligent methods of tuning

Movement disorder therapy system, devices and methods, and intelligent methods of tuning

Human I.kappa.B-.beta.

Intranasal compositions

Inhibitors of transcription factor-NF-.kappa.B

Movement disorder therapy system and methods of tuning remotely, intelligently and/or automatically

Movement disorder therapy system and methods of tuning remotely, intelligently and/or automatically

Movement disorder therapy system, devices and methods, and methods of remotely tuning

Movement disorder therapy system and methods of tuning remotely, intelligently and/or automatically

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of Neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

Induced expression of brain derived neurotrophic factor (BDNF) for treatment of neuromuscular, neurodegenerative, autoimmune, developmental and/or metabolic diseases

Activators of class I histone deacetlyases (HDACs) and uses thereof

Самая полная база данных о лекарственных травах, подтвержденная наукой